BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30460991)

  • 1. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
    Breuning J; Brown MH
    Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
    Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
    Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.
    Gimferrer I; Farnós M; Calvo M; Mittelbrunn M; Enrich C; Sánchez-Madrid F; Vives J; Lozano F
    J Biol Chem; 2003 Mar; 278(10):8564-71. PubMed ID: 12473675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
    Gonçalves CM; Henriques SN; Santos RF; Carmo AM
    Front Immunol; 2018; 9():2994. PubMed ID: 30619347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation.
    Castro MA; Nunes RJ; Oliveira MI; Tavares PA; Simões C; Parnes JR; Moreira A; Carmo AM
    J Leukoc Biol; 2003 Jan; 73(1):183-90. PubMed ID: 12525577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of CD6-mediated interactions in T cell activation and proliferation.
    Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
    J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
    Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex.
    Breuning J; Brown MH
    Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.
    Mori D; Grégoire C; Voisinne G; Celis-Gutierrez J; Aussel R; Girard L; Camus M; Marcellin M; Argenty J; Burlet-Schiltz O; Fiore F; Gonzalez de Peredo A; Malissen M; Roncagalli R; Malissen B
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33125054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
    Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
    Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
    Pinto M; Carmo AM
    BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
    Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
    Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
    Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
    Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
    Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
    Santos RF; Oliveira L; Brown MH; Carmo AM
    Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action.
    Garner LI; Hartland A; Breuning J; Brown MH
    Immunology; 2018 Oct; 155(2):273-282. PubMed ID: 29772075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
    Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
    J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
    Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
    Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.